Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00734435
Recruitment Status : Terminated (Sponsor Decision- Financial Considerations)
First Posted : August 14, 2008
Last Update Posted : November 29, 2012
Information provided by (Responsible Party):
Orexigen Therapeutics, Inc

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : December 2008
  Actual Study Completion Date : December 2008
  Certification/Extension First Submitted : November 27, 2012